Pancreatic cancer is one of the deadliest and most difficult-to-detect forms of cancer. It kills nearly half a million people ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into interactions between tumour cells and potential ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

Pancreatic cancer reprograms nerve cells to fuel its growth, but blocking these connections can shrink tumors and boost ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...